Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database
Drug, Healthcare and Patient Safety · 2020-11 · Volume 12 · 207-215
DOI: 10.2147/dhps.s257009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug, Healthcare and Patient Safety, 2020-11. Verfasst von Yumi Matsumura. Beteiligte Einrichtung: Department of Patient Safety, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Patient Safety, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
Zitieren
APA
Matsumura, Y. (2020). Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database. Drug, Healthcare and Patient Safety, Volume 12, 207-215. https://doi.org/10.2147/dhps.s257009
Vancouver
Matsumura Y. Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database. Drug, Healthcare and Patient Safety. 2020;Volume 12:207-215. doi:10.2147/dhps.s257009
BibTeX
@article{Matsumura2020,
author = {Matsumura, Yumi},
title = {Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database},
journal = {Drug, Healthcare and Patient Safety},
year = {2020},
volume = {Volume 12},
pages = {207--215},
doi = {10.2147/dhps.s257009}
}
EUVIMED